Bulletin
Investor Alert

New York Markets Open in:

GBS

IPO: US:GBSG

Company Description

Developing a saliva-based glucose monitoring system for diabetes in China.

Filing Information

File Date

7/3/2019

File Shares

N/A

Low Price Range

N/A

High Price Range

N/A

Proposed Offering Amount

$23,000,000

Exchange

Nasdaq

Underwriter Information

Bookrunner

Dawson James

Bookrunner

N/A

Bookrunner

N/A

At a Glance

Company

GBS

Address

City/State

New York, NY

Phone

N/A

Web

www.gbsgreaterchina.com

Industry

Health-Products

Employees

11

Founded

2016

Financial Information

Ltm Date

N/A

Ltm Sales

N/A

Employees

N/A

Use of Proceeds

Clinical trials, commercialization

IPO Discussion

MarketWatch News on GBSG

No news currently available
Link to MarketWatch's Slice.